cytl0001_2100021_207.docx CYNATA THERAPEUTICS LIMITED ACN 104 037 372 REPLACEMENT PROSPECTUS For a non-accelerated, renounceable pro rata entitlement offer of 3 New Shares for every 8 Shares held by Eligible Shareholders, and one free attaching Entitlement Option for every 3 New...